문레이크 이뮤노테라퓨틱스 (MLTX)

개요 뉴스 가격 이력 옵션 체인 Financials MLTX 왜 하락? 토론 예측

Moonlake Immunotherapeutics (MLTX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	8.70% 65.22	71.43	60.70	47.48	49.58
Operating Income/Loss	8.70% -65.22	-71.43	-60.70	-47.48	-49.58
Income/Loss From Continuing Operations Before Tax	11.06% -62.77	-70.58	-56.05	-40.56	-46.35
Income Tax Expense/Benefit	115.65% 0.248	0.115	0.095	0.153	0.0411
Income/Loss From Continuing Operations After Tax	10.86% -63.02	-70.69	-56.05	-40.56	-46.40
Net Income/Loss	10.86% -63.02	-70.69	-56.05	-40.56	-46.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	38.76% -0.591	-0.965	-0.831	-0.615	-0.7912
Basic Average Shares	98.16% 1.1679	63.37	63.28	63.23	0.067
Diluted Average Shares	98.16% 1.1679	63.37	63.28	63.23	0.067
Basic Earnings Per Share	16.36% -0.92	-1.10	-0.87	-0.63	-0.72
Diluted Earnings Per Share	16.36% -0.92	-1.10	-0.87	-0.63	-0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-